Markets:

Overview

News

Currencies

International

Treasuries

Calidi Biotherapeutics, Inc. Common Stock (NY:CLDI)

1.180 +0.010 (+0.85%)

Official Closing Price Updated: 8:00 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Calidi Biotherapeutics, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Calidi Biotherapeutics Announces Presentation of Clinical Study for NeuroNova with Recurrent High Grade Glioma at the 8th Oncolytic Virotherapy Summit

December 13, 2023

From Calidi Biotherapeutics, Inc.

Via Business Wire

Calidi Biotherapeutics Announces Appointment of Pharmaceutical Industry Veteran David LaPré to its Board of Directors

December 12, 2023

From Calidi Biotherapeutics, Inc.

Via Business Wire

Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform and Updates Anticipated Clinical Milestones

November 20, 2023

From Calidi Biotherapeutics, Inc.

Via Business Wire

Calidi Biotherapeutics Reports Third Quarter 2023 Operating and Financial Results

November 14, 2023

From Calidi Biotherapeutics, Inc.

Via Business Wire

Calidi Biotherapeutics (NYSEAM: CLDI) Presents Data on CLD-201 Demonstrating Inhibition of Tumor Growth and Induction of Robust Anti-Tumor Immunity at the Society for Immunotherapy of Cancer’s 38th Annual Meeting (SITC 2023)

November 03, 2023

From Calidi Biotherapeutics, Inc.

Via Business Wire

Calidi Biotherapeutics Announces Key Leadership Promotions and New Board Appointment

November 01, 2023

From Calidi Biotherapeutics, Inc.

Via Business Wire

Calidi Biotherapeutics Announces Appointment of Andrew Jackson as Chief Financial Officer

October 30, 2023

From Calidi Biotherapeutics, Inc.

Via Business Wire

Calidi Biotherapeutics To Present New Preclinical Data Highlighting Cell-based Virotherapy (SuperNova) Platform Technology at SITC 2023

October 10, 2023

From Calidi Biotherapeutics, Inc.

Via Business Wire

Analyst Bullish On Calidi Biotherapeutics, Newly Listed Cancer Treatment Player ↗

October 09, 2023

Baird initiates coverage on Calidi Biotherapeutics Inc (NYSE: CLDI), which uses allogeneic stem cells to deliver oncolytic viruses to tumors for cancer treatment.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 9, 2023 ↗

October 09, 2023

Via Benzinga

Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

September 25, 2023

Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138.

Via Benzinga

Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

September 22, 2023

Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enhanced backtracking search algorithm to boost the performance and efficiency of research institutions.

Via Benzinga

Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

September 20, 2023

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 104.5% to $0.1916.

Via Benzinga

Dow Turns Lower; KULR Technology Group Shares Plummet ↗

September 13, 2023

U.S. stocks traded mixed toward the end of trading, with the Dow Jones falling 100 points on Wednesday. The Dow traded down 0.29% to 34,545.66 while the NASDAQ rose 0.22% to 13,803.43. The S&P 500,...

Via Benzinga

Topics Stocks

Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

September 13, 2023

Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares surged 68% to $0.2075. Avalo Therapeutics, on Sept 12, got notice from the Nasdaq as of Sept 11 the company’s securities had closing bid price of...

Via Benzinga

Dow Gains 50 Points; US Crude Oil Inventories Rise ↗

September 13, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 50 points on Wednesday. The Dow traded up 0.16% to 34,701.06 while the NASDAQ rose 0.44% to 13,834.85. The S&P 500,...

Via Benzinga

Topics Stocks

Nasdaq Gains 50 Points; US Inflation Rate Rises In August ↗

September 13, 2023

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 50 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.11% to 34,685.47 while the NASDAQ...

Via Benzinga

Topics Economy Stocks

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.